BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamers OAC, Smits BM, Leavis HL, de Bree GJ, Cunningham-Rundles C, Dalm VASH, Ho HE, Hurst JR, IJspeert H, Prevaes SMPJ, Robinson A, van Stigt AC, Terheggen-Lagro S, van de Ven AAJM, Warnatz K, van de Wijgert JHHM, van Montfrans J. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review. Front Immunol 2021;12:606099. [PMID: 33936030 DOI: 10.3389/fimmu.2021.606099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Urdinez L, Erra L, Palma AM, Mercogliano MF, Fernandez JB, Prieto E, Goris V, Bernasconi A, Sanz M, Villa M, Bouso C, Caputi L, Quesada B, Solis D, Aguirre Bruzzo A, Katsicas MM, Galluzzo L, Weyersberg C, Bocian M, Bujan MM, Oleastro M, Almejun MB, Danielian S. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1020927] [Reference Citation Analysis]
2 Bintalib HM, Lowe DM, Mancuso G, Gkrepi G, Seneviratne SL, Burns SO, Hurst JR. Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort. ERJ Open Res 2022;8:00024-2022. [DOI: 10.1183/23120541.00024-2022] [Reference Citation Analysis]
3 Scarpa R, Landini N, Cinetto F, Milito C, Gianese S, Soccodato V, Buso H, Garzi G, Carrabba M, Messina E, Panebianco V, Morana G, Lougaris V, Catalano C, Bondioni MP. Common and uncommon CT findings in CVID related GL-ILD: correlations with clinical parameters, therapeutic decisions and potential implications in the differential diagnosis.. [DOI: 10.21203/rs.3.rs-2066296/v1] [Reference Citation Analysis]
4 Nishimura M, Miyata J, Tanigaki T, Nomura S, Serizawa Y, Igarashi S, Itou K, Ohno T, Kurata Y, Kimizuka Y, Fujikura Y, Sekinaka Y, Sekinaka K, Matsukuma S, Nonoyama S, Kawana A. Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency. Intern Med 2022. [PMID: 35945007 DOI: 10.2169/internalmedicine.0076-22] [Reference Citation Analysis]
5 Convers KD, Slack M, Kanarek HJ. Take a Leap of Faith: Implement Routine Genetic Testing in Your Office. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:1676-1687. [DOI: 10.1016/j.jaip.2022.05.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cabanero-Navalon MD, Garcia-Bustos V, Forero-Naranjo LF, Baettig-Arriagada EJ, Núñez-Beltrán M, Cañada-Martínez AJ, Forner Giner MJ, Catalán-Cáceres N, Martínez Francés M, Moral Moral P. Integrating Clinics, Laboratory, and Imaging for the Diagnosis of Common Variable Immunodeficiency-Related Granulomatous-Lymphocytic Interstitial Lung Disease. Front Immunol 2022;13:813491. [PMID: 35281075 DOI: 10.3389/fimmu.2022.813491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kosinski SM, Nachajon RV, Milman E. Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:876-878.e1. [DOI: 10.1016/j.jaip.2021.10.040] [Reference Citation Analysis]
8 Prasse A, Warnatz K. Interstitielle Lungenerkrankung bei CVID. Seltene Lungenerkrankungen 2022. [DOI: 10.1007/978-3-662-63651-0_25] [Reference Citation Analysis]
9 Chitty-lopez M, Walter JE. Immunomodulatory pharmaceuticals for the treatment of immune dysfunction. Allergic and Immunologic Diseases 2022. [DOI: 10.1016/b978-0-323-95061-9.00050-3] [Reference Citation Analysis]
10 Hurst JR, Abbas SH, Bintalib HM, Alfaro TM, Baumann U, Burns SO, Condliffe A, Davidsen JR, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Lamers O, Bergeron A, Malphettes M, Meignin V, Milito C, Milota T, Pergent M, Prasse A, Quinti I, Renzoni E, Sediva A, Stolz D, Smits B, Strauss F, van de Ven AAJM, van Montfrans J, Warnatz K. Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation. ERJ Open Res 2021;7:00467-2021. [PMID: 34881327 DOI: 10.1183/23120541.00467-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]